Select the name of the type of clinical care program you would like more information about …

Example: ‘B’ for Bladder Cancer

Cancer Treatment A-Z

Skip to content. | Skip to navigation

Personal tools


You are here: Home
7 items matching your search terms.
Filter the results.
Item type

New items since

Sort by relevance · date (newest first) · alphabetically
UNC scientists recommend rethinking brain MRI for early-stage lung cancer patients
by Mary Ruth published Oct 10, 2011 last modified Oct 10, 2011 02:02 PM — filed under: , ,
UNC scientists report that in early stage, asymptomatic non-small cell lung cancer, early brain recurrences are potentially detectable prior to surgery and recommend that physicians consider including a routine pre-operative staging brain MRI. In addition, patients whose tumors are determined to be higher risk based on the findings at surgery, should consider post-operative MRI to offer early treatment of unrecognized metastasis.
Located in News / 2011 News
Goldstein, McCullough address needed measures to curb tobacco use
by Mary Ruth published Dec 02, 2011 last modified Dec 02, 2011 01:16 PM — filed under: , ,
Located in News / 2011 News
Lung cancer highlights from 2011, Weiss provides insight
by Mary Ruth published Mar 22, 2012 last modified Mar 22, 2012 09:46 AM — filed under: , ,
Jared Weiss, MD, gave a podcast titled "2011 Highlights in Lung Cancer" that was posted on on March 15, 2012. In the podcast, Dr. Weiss talks about highlights in lung cancer from 2011 and also answers questions.
Located in News / 2012 News
Predictive biomarkers for lung cancer reported in laboratory finding
by Mary Ruth published Mar 26, 2012 last modified Mar 30, 2012 02:54 PM — filed under: , ,
A team of scientists, including several from UNC Lineberger, has identified predictive genetic biomarkers in pre-clinical models that affect response to therapy for non-small cell lung cancer (NSCLC). The study was done in parallel to an ongoing clinical trial among lung cancer patients at multiple institutions.
Located in News / 2012 News
Molecular subtypes and genetic alterations may determine response to lung cancer therapy
by Mary Ruth published May 11, 2012 last modified May 23, 2012 10:22 AM — filed under: , ,
Chapel Hill - Cancer therapies targeting specific molecular subtypes of the disease allow physicians to tailor treatment to a patient’s individual molecular profile. But scientists are finding that in many types of cancer the molecular subtypes are more varied than previously thought and contain further genetic alterations that can affect a patient’s response to therapy.
Located in News / 2012 News
UNC study highlights diagnosis of lung cancer subtypes
by Mary Ruth published May 17, 2012 last modified May 17, 2012 09:24 AM — filed under: , ,
In the processes of treating most cancers, one of the key pieces of information is the appearance of the tumor under the microscope using a technique called light microscopy. In lung cancer, for example, the appearance of the tumor determines both which chemotherapies are safe and which chemotherapies are effective. In addition, tumor appearance also suggests which patients should be tested for mutations that can be targeted by some of the most effective and safest drugs on the market.
Located in News / 2012 News
TCGA discovers potential therapeutic targets for lung squamous cell carcinoma
by Mary Ruth published Sep 10, 2012 last modified Sep 23, 2012 05:15 PM — filed under: , ,
Changes in DNA that are important to the initiation and progression of lung cancer also identified by NIH-supported researchers
Located in News / 2012 News